Moreover, African patients with very low CD4+ T cell counts have a high risk of mortality both before and during the initial months of ART[16,17] and advanced pre-treatment immunodeficiency is also reported to be associated with reduced capacity for restoration of CD4+ T cell counts and its functional responses during ART[18-20]. The gene discussed is CD4; the disease is immune system disorder.